Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SP500263

Known as: SP 500263 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Treatment with tamoxifen (TAM) increases the risk of developing endometrial cancer in women. The carcinogenic effect is thought… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Starting from a phenol screening hit (6), three series of benzopyranone selective estrogen receptor modulators (SERMs) have been… Expand
Is this relevant?
2003
2003
We describe here the activity of a novel selective estrogen receptor modulator, SP500263. When given to adult ovariectomized (OVX… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
We have compared the antitumor activities of SP500263, a novel next-generation selective estrogen receptor modulator (SERM… Expand
  • figure 1
  • figure 4
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2002
2002
We determined the differential response of a novel SERM, SP500263, on estrogen receptor (ER) alpha and the more recently cloned… Expand
Is this relevant?